本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kairos Pharma, Ltd.

0.8320
+0.02172.68%
盘后:0.83900.0070+0.84%19:56 EDT
成交量:25.11万
成交额:19.97万
市值:281.67万
市盈率:-0.43
高:0.8389
开:0.8145
低:0.7400
收:0.8103
52周最高:9.24
52周最低:0.7400
股本:338.54万
流通股本:224.75万
量比:0.07
换手率:11.17%
股息:- -
股息率:- -
每股收益(TTM):-1.9469
每股收益(LYR):-2.0691
净资产收益率:-113.96%
总资产收益率:-66.91%
市净率:0.67
市盈率(LYR):-0.40

数据加载中...

2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/10

重要事件披露

Form 8-K - Current report
2024/10/04

重要事件披露

Form 8-K - Current report
2024/09/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/27

重要事件披露

Form 8-K - Current report
2024/09/24

重要事件披露

Form 8-K - Current report
2024/09/17

重要事件披露

Form 8-K - Current report
2024/09/14

SEC问询函

Form CORRESP - Correspondence
2024/09/14

SEC问询函

Form CORRESP - Correspondence
2024/09/14

SEC问询函

Form CORRESP - Correspondence
2024/09/10

SEC问询函

Form CORRESP - Correspondence
2024/09/10

SEC问询函

Form CORRESP - Correspondence
2024/08/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/04

SEC问询函

Form CORRESP - Correspondence
2024/06/04

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]